Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Lancet. Microbe|October 2, 2023
Immunogenicity and safety of AZD2816, a beta (B.1.351) variant COVID-19 vaccine, and AZD1222 (ChAdOx1 nCoV-19) as third-dose boosters for previously vaccinated adults: a multicentre, randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study in the UK and PolandMaheshi N Ramasamy, Elizabeth J Kelly, Seth Seegobin, et al.
Nature|January 3, 2020
Prevention of tuberculosis in macaques after intravenous BCG immunizationPatricia A Darrah, Joseph J Zeppa, Pauline Maiello, et al.
Frontiers in Immunology|January 30, 2023
Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinatedJill Maaske, Stephanie Sproule, Ann R Falsey, et al.
Nature Medicine|September 14, 2021
Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trialMartina Oneko, Laura C Steinhardt, Reuben Yego, et al.
The Journal of Clinical Investigation|January 9, 2024
Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adultsSaid Jongo, L W Preston Church, Florence Milando, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2019
Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian AdultsSaid A Jongo, L W Preston Church, Ali T Mtoro, et al.
The American Journal of Tropical Medicine and Hygiene|April 18, 2019
Safety and Differential Antibody and T-Cell Responses to the <i>Plasmodium falciparum</i> Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and InfantsSaid A Jongo, L W Preston Church, Ali T Mtoro, et al.
JCI Insight|April 30, 2024
Innate immune activation restricts priming and protective efficacy of the radiation-attenuated PfSPZ malaria vaccineLeetah Senkpeil, Jyoti Bhardwaj, Morgan R Little, et al.
The New England Journal of Medicine|July 15, 2020
An mRNA Vaccine against SARS-CoV-2 - Preliminary ReportLisa A Jackson, Evan J Anderson, Nadine G Rouphael, et al.
The New England Journal of Medicine|September 29, 2020
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older AdultsEvan J Anderson, Nadine G Rouphael, Alicia T Widge, et al.
Pageof 3